These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 32536911)

  • 21. Detection of anti-C1q antibodies and anti-C1q globular head domain antibodies in sera from Chinese patients with lupus nephritis.
    Tan Y; Zhou W; Yu F; Fang Q; Yang HZ; Zhao MH
    Mol Immunol; 2009 Jul; 46(11-12):2178-82. PubMed ID: 19481805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C1q as antigen in humoral autoimmune responses.
    Siegert CE; Daha MR
    Immunobiology; 1998 Aug; 199(2):295-302. PubMed ID: 9777413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-C1q in systemic lupus erythematosus.
    Stojan G; Petri M
    Lupus; 2016 Jul; 25(8):873-7. PubMed ID: 27252264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies against Complement Classical Pathway Components C1q, C1r, C1s and C1-Inh in Patients with Lupus Nephritis.
    Radanova M; Vasilev V; Mihaylova G; Kosturkova M; Kishore U; Roumenina L
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
    Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New insight into the autoimmunogenicity of the complement protein C1q.
    Stoyanova V; Petrova S; Tchorbadjieva M; Deliyska B; Vasilev V; Tsacheva I
    Mol Immunol; 2011 Jan; 48(4):678-82. PubMed ID: 21159384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus.
    Frémeaux-Bacchi V; Weiss L; Demouchy C; Blouin J; Kazatchkine MD
    Lupus; 1996 Jun; 5(3):216-20. PubMed ID: 8803893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis.
    Bigler C; Hopfer H; Danner D; Schaller M; Mihatsch MJ; Trendelenburg M
    Nephrol Dial Transplant; 2011 Apr; 26(4):1220-8. PubMed ID: 20841491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare.
    Birmingham DJ; Bitter JE; Ndukwe EG; Dials S; Gullo TR; Conroy S; Nagaraja HN; Rovin BH; Hebert LA
    Clin J Am Soc Nephrol; 2016 Jan; 11(1):47-53. PubMed ID: 26700439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
    Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-C1q autoantibodies in lupus nephritis.
    Sinico RA; Rimoldi L; Radice A; Bianchi L; Gallelli B; Moroni G
    Ann N Y Acad Sci; 2009 Sep; 1173():47-51. PubMed ID: 19758131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relevance of anti-C1q autoantibodies to lupus nephritis.
    Tsirogianni A; Pipi E; Soufleros K
    Ann N Y Acad Sci; 2009 Sep; 1173():243-51. PubMed ID: 19758158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement component c1q and anti-c1q antibodies in theory and in clinical practice.
    Potlukova E; Kralikova P
    Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus.
    Gunnarsson I; Rönnelid J; Huang YH; Rogberg S; Nilsson B; Lundberg I; Klareskog L
    Br J Rheumatol; 1997 Jan; 36(1):32-7. PubMed ID: 9117171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Idiotype scFv Localizes an Autoepitope in the Globular Domain of C1q.
    Todorova N; Rangelov M; Bogoeva V; Stoyanova V; Yordanova A; Nikolova G; Georgiev H; Dimitrova D; Mohedin S; Stoyanova K; Tsacheva I
    Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
    Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
    Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of anti-C1qA08 and anti-mCRP a.a.35-47 antibodies is associated with renal prognosis of patients with lupus nephritis.
    Liu XL; Tan Y; Yu F; Ji SR; Zhao MH
    Front Immunol; 2023; 14():1181561. PubMed ID: 37138875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of reactivity of monoclonal autoantibodies with renal antigens in experimental lupus nephritis.
    Kootstra JC; Veninga A; Baelde JJ; van Eendenburg J; de Heer E; Bruijn JA
    J Clin Lab Immunol; 1996; 48(5):201-18. PubMed ID: 9394243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-complement factor H (CFH) autoantibodies could delay pristane-induced lupus nephritis.
    Li LL; Luan ZQ; Tan Y; Wang H; Yu XJ; Qu Z; Yu F; Chen M
    Immunol Res; 2023 Dec; 71(6):849-859. PubMed ID: 37322353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interference of antimodified C-reactive protein autoantibodies from lupus nephritis in the biofunctions of modified C-reactive protein.
    Yang XW; Tan Y; Yu F; Zhao MH
    Hum Immunol; 2012 Feb; 73(2):156-63. PubMed ID: 22192784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.